375 related articles for article (PubMed ID: 9833724)
1. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
3. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation.
Koster A; Fischer T; Gruendel M; Mappes A; Kuebler WM; Bauer M; Kuppe H
J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):171-5. PubMed ID: 12698397
[TBL] [Abstract][Full Text] [Related]
4. Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model.
Walenga JM; Bakhos M; Messmore HL; Koza M; Wallock M; Orfei E; Fareed J; Pifarre R
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):105-11. PubMed ID: 1772977
[TBL] [Abstract][Full Text] [Related]
5. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia.
Longrois D; de Maistre E; Bischoff N; Dopff C; Meistelman C; Angioï M; Lecompte T
Can J Anaesth; 2000 Mar; 47(3):255-60. PubMed ID: 10730738
[TBL] [Abstract][Full Text] [Related]
6. The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery.
Despotis GJ; Hogue CW; Saleem R; Bigham M; Skubas N; Apostolidou I; Qayum A; Joist JH
Anesth Analg; 2001 Jul; 93(1):28-32. PubMed ID: 11429333
[TBL] [Abstract][Full Text] [Related]
7. Determination of the dosage of recombinant hirudin to inhibit arterial thrombosis in baboons.
Kotzé HF; Lamprecht S; Van Wyk V; Roodt JP; Badenhorst PN
J Pharm Sci; 2000 May; 89(5):579-85. PubMed ID: 10756323
[TBL] [Abstract][Full Text] [Related]
8. Potential use of recombinant hirudin as an anticoagulant in a cardiopulmonary bypass model.
Walenga JM; Bakhos M; Messmore HL; Fareed J; Pifarre R
Ann Thorac Surg; 1991 Feb; 51(2):271-7. PubMed ID: 1989543
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass.
Terrell MR; Walenga JM; Koza MJ; Pifarré R
Ann Thorac Surg; 1996 Aug; 62(2):506-11. PubMed ID: 8694614
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
[TBL] [Abstract][Full Text] [Related]
11. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
13. Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.
Riess FC; Poetzsch B; Madlener K; Cramer E; Doll KN; Doll S; Lorke DE; Kormann J; Mueller-Berghaus G
Thorac Cardiovasc Surg; 2007 Jun; 55(4):233-8. PubMed ID: 17546553
[TBL] [Abstract][Full Text] [Related]
14. Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series.
Chryssos A; Stroup SJ; Pifer MM; Tawil M; Conrad CG
J Extra Corpor Technol; 2015 Mar; 47(1):44-7. PubMed ID: 26390679
[TBL] [Abstract][Full Text] [Related]
15. Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model.
Riess FC; Pötzsch B; Behr I; Jäger K; Rössing R; Bleese N; Schaper W; Müller-Berghaus G
Eur J Cardiothorac Surg; 1997 Apr; 11(4):739-45. PubMed ID: 9151047
[TBL] [Abstract][Full Text] [Related]
16. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
Imura Y; Stassen JM; Collen D
J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
[TBL] [Abstract][Full Text] [Related]
17. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
[TBL] [Abstract][Full Text] [Related]
18. Effect of combined anticoagulation using heparin and bivalirudin on the hemostatic and inflammatory responses to cardiopulmonary bypass in the rat.
Welsby IJ; Jones WL; Arepally G; De Lange F; Yoshitani K; Phillips-Bute B; Grocott HP; Becker R; Mackensen GB
Anesthesiology; 2007 Feb; 106(2):295-301. PubMed ID: 17264724
[TBL] [Abstract][Full Text] [Related]
19. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous use of argatroban and heparin during cardiopulmonary bypass.
Okamura T; Shin'oka T; Ishibashi N; Ishii H; Kurosawa H
Asian Cardiovasc Thorac Ann; 2010 Feb; 18(1):22-6. PubMed ID: 20124292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
